Nicholas S. Green

2021

In 2021, Nicholas S. Green earned a total compensation of $2.8M as President and Chief Executive Officer at Peregrine Pharmaceuticals.

Compensation breakdown

Bonus$137,500
Non-Equity Incentive Plan$723,227
Option Awards$347,153
Salary$420,962
Stock Awards$1,089,000
Other$127,441
Total$2,845,283

Green received $1.1M in stock awards, accounting for 38% of the total pay in 2021.

Green also received $137.5K in bonus, $723.2K in non-equity incentive plan, $347.2K in option awards, $421K in salary and $127.4K in other compensation.

Rankings

In 2021, Nicholas S. Green's compensation ranked 4,638th out of 12,415 executives tracked by ExecPay. In other words, Green earned more than 62.6% of executives.

ClassificationRankingPercentile
All
4,638
out of 12,415
63rd
Division
Manufacturing
1,923
out of 5,505
65th
Major group
Chemicals And Allied Products
803
out of 2,375
66th
Industry group
Drugs
716
out of 2,096
66th
Industry
Pharmaceutical Preparations
510
out of 1,546
67th

Pay ratio

Nicholas S. Green's Pay$2,845,283
Median Employee's Pay$104,222
Pay Ratio

27

to 1

In 2021, the annual total compensation of Nicholas S. Green was $2,845,283.

The annual total compensation of the median employee at Peregrine Pharmaceuticals was $104,222.

The ratio of Nicholas S. Green's pay to the pay of median employee was therefore 27 to one.

Source: SEC filing on August 27, 2021.

Green's colleagues

We found three more compensation records of executives who worked with Nicholas S. Green at Peregrine Pharmaceuticals in 2021.

2021

Daniel Hart

Peregrine Pharmaceuticals

Chief Financial Officer

2021

Mark Ziebell

Peregrine Pharmaceuticals

General Counsel

2021

Richard Hancock

Peregrine Pharmaceuticals

Chief Executive Officer

News

You may also like